AKT1 and Sepsis: Prior research has shown that the AKT pathway can enhance resistance to LPS by attenuating the expression of pro-inflammatory cytokines [45] and apoptosis [46], inhibiting the translocation of NF-kappa B nuclear [45] and autophagy [47], elevating the activity of total nitric oxide synthase [48] in sepsis.